The changes of antiphospholipid antibody levels under the treatment in patients with antiphospholipid syndrome.
| aCL IgG/IgM | LAC | ||||||
|---|---|---|---|---|---|---|---|
| Cases, age/sex | Treatment | 0 mo | 6 mo | 12 mo | 0 mo | 6 mo | 12 mo |
| 1. 35/F | CYC + PRD | 35/18 | 1.3/1 | 8/5 | + | ND | − |
| 2. 40/F | AZA + PRD | 13/2 | 6/20 | 12/18 | + | − | − |
| 3. 30/F | AZA | 9/7 | 11/17 | 7/24 | + | + | + |
| 4. 36/F | CYC + PRD | 61/42 | 2/2 | 20/2 | − | ND | − |
aCL: anticardiolipin antibody; LAC: lupus anticoagulant; CYC: cyclophosphamide; AZA: azathioprine; PRD: prednisolone; ND: not done. Positivity for aCL IgG > 12 GPL units; for aCL IgM > 11 MPL units.